1. Benedicto-Rodríguez G, Hongn A, Juan CG, Garrigós-Guerrero J, Bonomini MP, Fernandez-Jover E, Ferrández-Vicente JM. Physiological Response in Children with…
1. Akalin H, Bilgic B, Avcil S, Orenay-Boyacioglu S. Low Expression Levels of MAOA and TPH1 Genes May Represent Risk…
1. Albin M, Chawrun I, Tint A. Rethinking Social Communication Support: Exploring Communication Partner Training for Autistic Adults and Their…
1. Amaral JZ, Kallur A, Dolan LA, Nguyen AQ, Schultz RJ, Martin BM, Coello P, Scioscia JP, Chhabra BN, Hanson…
1. Ahsan A, Kar O, Akter K, Ta HDK, Shen CJ, Datta K, Chatterjee B, Huang CC, Majumder P. Regulatory…
1. Akalin H, Bilgic B, Avcil S, Orenay-Boyacioglu S. Low Expression Levels of MAOA and TPH1 Genes May Represent Risk…
1. Cheng Y, Shi J, Wei Y, Luo J, Shi Y, Jiang Z. Psychometric properties and screening accuracy of the…
1. Aragão GF, Brandão CB, Júnior JEL. Cannabidiol in autism: Clinical pharmacology priorities for trial design. Br J Clin Pharmacol.…
1. Correction to « Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder ». Clin Pharmacol…
© 2026 Copyright Centre de Ressources Autisme Rhône-Alpes – CRA Rhône-Alpes - Mentions Légales .
